Increased oxysterol contents in diabetic rat hearts: Their involvement in diabetic cardiomyopathy

Canadian Journal of Cardiology

Volumn 13, Issue 4, 1997, Pages 373-379

  Matsui, Hideo ^a   Okumura, Kenji ^a   Mukawa, Hiroaki ^a   Hibino, Michitaka ^a   Toki, Yukio ^a   Ito, Takayuki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

7 hydroxycholesterol; 7 ketocholesterol; Diabetic cardiomyopathy; Oxysterols; Probucol

Indexed keywords

7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ANTILIPEMIC AGENT; PROBUCOL;

ANIMAL EXPERIMENT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE METABOLISM; INSULIN DEFICIENCY; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NONHUMAN; PATHOGENESIS; RAT; STREPTOZOCIN DIABETES;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; HYDROXYCHOLESTEROLS; KETOCHOLESTEROLS; LIPID PEROXIDATION; MALE; MYOCARDIUM; PROBUCOL; RATS; RATS, WISTAR;

EID: 0030902933     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA 1974;229:1749-54.
2. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595-602.
3. Regan TJ, Lyons MM, Ahmed SS, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977;60:885-99.
4. Tahiliani AG, McNeill JH. Diabetes-induced abnormalities in the myocardium. Life Sci 1986;38:959-74.
5. Akiyama N, Okumura K, Watanabe Y, et al. Altered acetylcholine and norepinephrine concentrations in diabetic rat hearts. Role of parasympathetic nervous system in diabetic cardiomyopathy. Diabetes 1989;38:231-6.
6. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985;27:255-70.
7. Dhalla NS, Pierce GN, Innes IR, Beamish RE. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1985;1:263-81.
8. Gøtzsche O. Myocardial cell dysfunction in diabetes mellitus, A review of clinical and experimental studies. Diabetes 1986;35:1158-62.
9. + and Ca currents in ventricular myocytes from rats with chronic diabetes. Am J Physiol 1995;269(Heart Circ Physiol 38):H1288-96.
10. Regan TJ, Ettinger PO, Khan MI, et al. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs Circ Res 1974;35:222-37.
11. Peng SK, Tham P, Taylor CB, Mikkelson B. Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis. Am J Clin Nutr 1979;32:1033-42.
12. Sevanian A, Peterson AR. Cholesterol epoxide is a direct-acting mutagen. Proc Natl Acad Sci USA 1984;81:4198-202.
13. Humphries GMK, McConnell HM. Potent immunosuppression by oxidized cholesterol. J Immunol 1979;122:121-6.
14. Hwang PLH. Inhibitors of protein and RNA synthesis block the cytotoxic effects of oxygenated sterols. Biochim Biophys Acta 1992;1136:5-11.
15. Parish EJ, Nanduri VBB, Kohl HH, Taylor FR. Oxysterols: chemical synthesis, biosynthesis and biological activities. Lipids 1986;21:27-30.
16. Hughes H, Mathews B, Lenz ML, Guyton LR. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler Thromb 1994;14:1177-85.
17. Gangopadhyay H, Cordis GA, Jones R, Liu X, Das DK. Capillary gas chromatography for the assessment of cholesterol oxides in the heart. J Pharm Biomed Anal 1991;9:1003-8.
18. Morel DW, Chisolm GM Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 1989;30:1827-34.
19. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986;77:641-4.
20. Kita T, Nagano Y, Yokode M, et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928-31.
21. O'Brien K, Nagano Y, Gown A, KitaT, Chait A. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 1991;11:751-9.
22. Hodis HN, Chauhan A, Hashimoto S, Crawford DW, Sevanian A. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. Atherosclerosis 1992;96:125-34.
23. Hodis HN, Crawford DW, Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 1991;89:117-26.
24. Maerker G, Unruh J Jr. Cholesterol oxides 1. Isolation and determination of some cholesterol oxidation products. J Am Oil Chem Soc 1986;63:767-71.
25. Okumura K, Akiyama N, Hashimoto H, Ogawa K, Satake T. Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes 1988;37:1168-72.
26. Okumura K, Nishiura T, Awaji Y, Kondo J, Hashimoto H, Ito T. 1,2-diacylglycerol content and its fatty acid composition in thoracic aorta of diabetic rats. Diabetes 1991;40:820-4.
27. Van de Bovenkamp P, Kosmeijer-Schuil TG, Katan MB. Quantification of oxysterols in Dutch foods: egg products and mixed diets. Lipids 1988;23:1079-85.
28. Tsai LS, Ijichi K, Hudson CA, Meehan JJ. A method for the quantitative estimation of cholesterol ∂-oxide in eggs. Lipids 1980;15:124-8.
29. Kallen K-J, Allan D, Whatmore J, Quinn P. Synthesis of surface sphingomyelin in the plasma membrane recycling pathway of BHK cells. Biochem Biophys Acta 1994;1191:52-3.
30. Hostetler KY, Zenner BD, Morris HP. Phospholipid content of mitochondrial and microsomal membranes from Morris hepatomas of varying growth rates. Cancer Res 1979;39:2978-83.
31. Yechiel E, Henis YI, Barenholz Y. Aging of rat heart fibroblasts: relationship between lipid composition, membrane organization and biological properties. Biochem Biophys Acta 1986;859:95-104.
32. Kolesnick RN. Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 1991;30:1-38.
33. Holman RT, Johnson SB, Gerrard JM, Mauer SM, Kupcho-Sandberg S, Brown DM. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1983;80:2375-9.
34. Dang AQ, Kemp K, Faas FH, Carter WJ. Effects of dietary fats on fatty acid composition and Δ5 desaturase in normal and diabetic rats. Lipids 1989;24:882-9.
35. Ramsammy LS, Haynes B, Josepovitz C, Kaloyanides GJ. Mechanism of decreased arachidonic acid in the renal cortex of rats with diabetes mellitus. Lipids 1993;28:433-9.
36. Slater TF. Free-radical mechanisms in tissue injury. Biochem J 1984;222:1-15.
37. Freyschuss A, Stiko-Rahm A, Swedenborg J, et al. Antioxidant treatment inhibits the development of intimai thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest 1993;91:1282-8.
38. Yoshino G, Matsushita M, Maeda E, et al. Effect of probucol on triglyceride turnover in streptozotocin-diabetes rats. Atherosclerosis 1991;88:69-75.